CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target.

Hansel DE, Dhara S, Huang RC, Ashfaq R, Deasel M, Shimada Y, Bernstein HS, Harmon J, Brock M, Forastiere A, Washington MK, Maitra A, Montgomery E
Am J Surg Pathol. 2005 29 (3): 390-9

PMID: 15725809 · DOI:10.1097/00000478-200503000-00014

MeSH Terms (19)

Adenocarcinoma Barrett Esophagus CDC2 Protein Kinase Cell Cycle Proteins Cell Line, Tumor Cell Proliferation Disease Progression Dose-Response Relationship, Drug Esophageal Neoplasms Esophagus Gene Expression Profiling Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Masoprocol Precancerous Conditions RNA, Messenger RNA, Neoplasm Tissue Array Analysis

Connections (1)

This publication is referenced by other Labnodes entities: